| Name |
Fusicutan Plus 20 mg/g + 1 mg/g krema |
| Marketing Authorisation Number |
HR-H-807587009 |
| Active Substance |
fusidatna kiselina hemihidrat, betametazonvalerat |
| Composition |
1 g kreme sadrži 20,4 mg fusidatne kiseline 0,5 H2O (ekvivalentno 20 mg fusidatne kiseline) i 1,214 mg betametazonvalerata (ekvivalentno 1 mg betametazona) |
| Pharmaceutical Form |
krema |
| Manufacturer |
mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder |
Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date |
01.07.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/20-02/125 |
| Registration Number |
381-12-01/70-21-04 |
| Prescription |
na recept |
| Type of prescription |
neponovljivi recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
D07CC01 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
